Add to ORKGCertolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patient
Objectives: To investigate the clinical impact of 1-year certolizumab pegol (CZP) therapy added to t...
Objectives. To evaluate the long-term efficacy and safety of certolizumab pegol (CZP) plus methotrex...
Methotrexate (MTX) has been used in the treatment of rheumatoid arthritis for more than 2 decades. I...
Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation wi...
To examine the safety and efficacy of 5-year administration of certolizumab pegol (CZP)+methotrexate...
IntroductionAs patients with rheumatoid arthritis (RA) receive treatment with anti-tumour necrosis f...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Supplementary material. Additional supplementary data tables and figures referred to in the manuscri...
efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPI...
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatmen...
Certolizumab pegol, a pegylated Fab' anti-tumour necrosis factor (TNF)-α agent, has shown efficacy i...
Certolizumab pegol, a pegylated Fab' anti-tumour necrosis factor (TNF)-α agent, has shown efficacy i...
Abstract Certolizumab pegol, a pegylated Fab' anti-tumour necrosis factor (TNF)-α agent, has shown ...
Background/Aims: The objective of this study was to determine the efficacy and safety of add-on ther...
Objectives: To investigate the clinical impact of 1-year certolizumab pegol (CZP) therapy added to t...
Objectives. To evaluate the long-term efficacy and safety of certolizumab pegol (CZP) plus methotrex...
Methotrexate (MTX) has been used in the treatment of rheumatoid arthritis for more than 2 decades. I...
Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation wi...
To examine the safety and efficacy of 5-year administration of certolizumab pegol (CZP)+methotrexate...
IntroductionAs patients with rheumatoid arthritis (RA) receive treatment with anti-tumour necrosis f...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Supplementary material. Additional supplementary data tables and figures referred to in the manuscri...
efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPI...
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatmen...
Certolizumab pegol, a pegylated Fab' anti-tumour necrosis factor (TNF)-α agent, has shown efficacy i...
Certolizumab pegol, a pegylated Fab' anti-tumour necrosis factor (TNF)-α agent, has shown efficacy i...
Abstract Certolizumab pegol, a pegylated Fab' anti-tumour necrosis factor (TNF)-α agent, has shown ...
Background/Aims: The objective of this study was to determine the efficacy and safety of add-on ther...
Objectives: To investigate the clinical impact of 1-year certolizumab pegol (CZP) therapy added to t...
Objectives. To evaluate the long-term efficacy and safety of certolizumab pegol (CZP) plus methotrex...
Methotrexate (MTX) has been used in the treatment of rheumatoid arthritis for more than 2 decades. I...